Literature DB >> 33730167

National Changes in Outpatient Systemic Antibiotic Use During the Coronavirus Disease 2019 (COVID-19) Pandemic in Australia.

Janet K Sluggett1,2,3, Yen H Dinh4, Steven L Wesselingh2,5, Maria C Inacio1,2, Gillian E Caughey1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33730167      PMCID： PMC7989528          DOI： 10.1093/cid/ciab241

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  4 in total

1.  Changes in antibiotic prescribing following COVID-19 restrictions: Lessons for post-pandemic antibiotic stewardship.

Authors:  Malcolm B Gillies; David P Burgner; Lorraine Ivancic; Natasha Nassar; Jessica E Miller; Sheena G Sullivan; Isobel M F Todd; Sallie-Anne Pearson; Andrea L Schaffer; Helga Zoega
Journal:  Br J Clin Pharmacol       Date:  2021-08-17       Impact factor: 3.716

2.  Outpatient Antibiotic Prescriptions in France: Patients and Providers Characteristics and Impact of the COVID-19 Pandemic.

Authors:  Wilfried Bara; Christian Brun-Buisson; Bruno Coignard; Laurence Watier
Journal:  Antibiotics (Basel)       Date:  2022-05-11

Review 3.  COVID-19: Impact on prescribing and antimicrobial resistance.

Authors:  P Ruiz-Garbajosa; R Cantón
Journal:  Rev Esp Quimioter       Date:  2021-09-30       Impact factor: 1.553

4.  Azithromycin consumption during the COVID-19 pandemic in Croatia, 2020.

Authors:  Nikolina Bogdanić; Loris Močibob; Toni Vidović; Ana Soldo; Josip Begovać
Journal:  PLoS One       Date:  2022-02-02       Impact factor: 3.752
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.